Low Anterior Resection Syndrome Clinical Trial
Official title:
Real World Evaluation of the Effect of Gelsectan® in Low Anterior Resection Syndrome Patients: a Pilot Prospective Case-series Pilot Study (GeLAR)
Low Anterior Resection Syndrome (LARS) is an intestinal disorder affecting patients undergoing rectal resection for rectal cancer. A possible therapeutic option may be Gelsectan®, a class II device used in Irritable Bowel Syndrome (IBS). The aim of this study is to evaluate the efficacy of Gelsectan® in improving the symptoms of LARS.
Low Anterior Resection Syndrome (LARS) affects almost 70% of patients after rectal resection for rectal cancer and is characterized by intestinal symptoms including urgency, fractioned defecation, and fecal incontinence. LARS is clinically diagnosed using the LARS score: a score higher than 21 indicates the presence of LARS and a score higher than 30 indicates severe LARS. The treatment opportunities for LARS are limited and failure rates are high. Gelsectan® is a class II device containing xyloglucans, xylo-oligosaccharides, pea proteins, and tannins from grape seeds extract, resulting effective in improving intestinal symptoms in patients with diarrheic Irritable Bowel Syndrome (IBS). Given the symptomatic similarities between LARS and IBS, Gelsectan® may represent a valid first line treatment for LARS patients. The objective of this study is to provide preliminary data to determine whether the administration of Gelsectan® may ameliorate the symptoms of LARS. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04087421 -
Comparison of Transanal Irrigation and Glycerol Suppositories in Treatment of Low Anterior Resection Syndrome
|
Phase 3 | |
| Recruiting |
NCT04023448 -
The Effect of Different Reconstruction Methods on Anterior Resection Syndrome
|
N/A | |
| Recruiting |
NCT04040842 -
International Low Anterior Resection Score Evaluation
|
||
| Recruiting |
NCT03828318 -
Impact of a Patient-Centered Program for Low Anterior Resection Syndrome A Multicenter Randomized Controlled Trial
|
N/A | |
| Completed |
NCT05605600 -
Translation of the International Consensus Definition of LARS Into a Bowl Dysfunction Severity Scoring Tool (New LARS Score)
|
||
| Completed |
NCT05016583 -
Paula Method of Exercises in Patients With LARS Syndrome
|
N/A | |
| Active, not recruiting |
NCT05042700 -
The Effect of Melatonin in Patients With Low Anterior Resection Syndrome
|
Phase 2 | |
| Recruiting |
NCT04612569 -
Feasibility and Impact of a Prehabilitation and Rehabilitation Program for the Continuity of Care in Severe Low Anterior Resection Syndrome.
|
||
| Completed |
NCT04896879 -
Experiences and Needs of Patients, Their Informal Caregiver and Healthcare Professionals Regarding LARS
|
||
| Withdrawn |
NCT03257332 -
Determining Early Development of Faecal Incontinence and Anorectal Muscle Function After Surgery for Rectal Cancer.
|
||
| Completed |
NCT03916549 -
Acupuncture in Low Anterior Resection Syndrome Treatment
|
Phase 1 | |
| Completed |
NCT05020132 -
Bowel Dysfunction After Rectal Cancer Treatment
|
||
| Completed |
NCT03598231 -
Effectiveness of Sacral Neuromodulation in Low Anterior Resection Syndrome
|
N/A | |
| Recruiting |
NCT05420870 -
Effect of Exercise on Bowel Function in Colorectal Cancer Survivors
|
N/A | |
| Active, not recruiting |
NCT05319054 -
Pathway of Low Anterior Resection Syndrome Relief After Surgery: a Feasibility Study
|
N/A | |
| Completed |
NCT01589471 -
The Value of Botox-A for Management of Low Anterior Resection Syndrome
|
Phase 2 | |
| Completed |
NCT03215017 -
Effect of Treatment of Low Anterior Resection Syndrome After Rectal Cancer Surgery
|
N/A | |
| Completed |
NCT05129215 -
Development and Validation of The Post-RT LARS Prediction Model (PORTLARS)
|
||
| Recruiting |
NCT05682157 -
Paula Method of Exercises in Patients With LARS Syndrome:Randomized Controlled Trial
|
N/A | |
| Completed |
NCT06059170 -
Rectal Cancer Survivorship: Impact of Low Anterior Resection Syndrome (LARS) on the Quality of Life
|
N/A |